Company press releases

Displaying 51 - 100 of 129 results
Released Company Title Industry Topic
28 Mar 2023
07:30 CEST 		THERAVET TheraVet fait le point sur sa stratégie de développement et de portefeuille produits 20103015 Pharmaceuticals Other subject
28 Mar 2023
07:30 CEST 		THERAVET TheraVet Updates on Its Development and Portfolio Strategy 20103015 Pharmaceuticals Other subject
21 Feb 2023
07:30 CET 		THERAVET TheraVet signe un accord de distribution à l’international pour BIOCERA-VET® couvrant 24 pays 20103015 Pharmaceuticals News contracts
21 Feb 2023
07:30 CET 		THERAVET TheraVet Signs an International Distribution Agreement for BIOCERA-VET® Covering 24 Countries 20103015 Pharmaceuticals News contracts
15 Feb 2023
17:45 CET 		THERAVET TheraVet Announces the Start of the Assessment of BIOCERA-VET® in Horse Bone Cyst 20103015 Pharmaceuticals Other subject
15 Feb 2023
17:45 CET 		THERAVET TheraVet annonce le début de l'évaluation de BIOCERA-VET® dans le traitement du kyste osseux chez le cheval 20103015 Pharmaceuticals Other subject
12 Dec 2022
07:30 CET 		THERAVET TheraVet Optimizes Its Commercial Strategy in France With a New Distribution Agreement for Its BIOCERA-VET® Range 20103015 Pharmaceuticals News contracts
12 Dec 2022
07:30 CET 		THERAVET TheraVet optimise sa stratégie commerciale en France avec un nouvel accord de distribution pour sa gamme BIOCERA-VET® 20103015 Pharmaceuticals News contracts
07 Dec 2022
07:30 CET 		THERAVET TheraVet: BIOCERA-VET® Nominated for the Veterinary Innovation Award (AFVAC 2022) 20103015 Pharmaceuticals Other subject
07 Dec 2022
07:30 CET 		THERAVET TheraVet : BIOCERA-VET® nominé au Prix de l’Innovation Vétérinaire (AFVAC 2022) 20103015 Pharmaceuticals Other subject
26 Sep 2022
07:30 CEST 		THERAVET TheraVet Announces an Exclusive Distribution Agreement for BIOCERA-VET® in the USA 20103015 Pharmaceuticals News contracts
26 Sep 2022
07:30 CEST 		THERAVET TheraVet annonce un accord de distribution exclusif pour BIOCERA-VET® aux États-Unis 20103015 Pharmaceuticals News contracts
19 Sep 2022
07:30 CEST 		THERAVET TheraVet annonce sa participation au congrès de l’ESVOT 2022 avec 3 communications scientifiques 20103015 Pharmaceuticals Meetings / events
19 Sep 2022
07:30 CEST 		THERAVET TheraVet Announces Its Participation in the 2022 ESVOT Congress With 3 Scientific Communications 20103015 Pharmaceuticals Meetings / events
09 Sep 2022
07:30 CEST 		THERAVET TheraVet publie ses résultats financiers du 1er semestre 2022 et fait le point sur le développement de ses activités 20103015 Pharmaceuticals Other subject
09 Sep 2022
07:30 CEST 		THERAVET TheraVet Reports Its 2022 Half-year Results and Provides an Update on the Development of Its Activities 20103015 Pharmaceuticals Other subject
30 Jun 2022
17:45 CEST 		THERAVET TheraVet publie son point d’activité du 1er semestre 2022 20103015 Pharmaceuticals Other subject
30 Jun 2022
17:45 CEST 		THERAVET TheraVet Provides Its 2022 First Half-year Operational Update 20103015 Pharmaceuticals Other subject
30 Jun 2022
07:30 CEST 		THERAVET TheraVet annonce le lancement commercial de sa gamme de produits BIOCERA-VET® aux États-Unis 20103015 Pharmaceuticals Other subject
30 Jun 2022
07:30 CEST 		THERAVET TheraVet Annonces the Commercial Launch of its BIOCERA-VET Product Line in the United States of America 20103015 Pharmaceuticals Other subject
02 Jun 2022
07:30 CEST 		THERAVET TheraVet Annonces the Commercial Launch of the Most Comprehensive Line of Bone Substitutes in the Veterinary Market 20103015 Pharmaceuticals Other subject
02 Jun 2022
07:30 CEST 		THERAVET TheraVet annonce le lancement de la gamme de substituts osseux la plus complète pour le marché vétérinaire 20103015 Pharmaceuticals Other subject
30 May 2022
07:30 CEST 		THERAVET TheraVet Signs a Distribution Agreement With Nuzoa, a Leading Spanish Company in the Distribution of Veterinary Products and Services 20103015 Pharmaceuticals Other subject
30 May 2022
07:30 CEST 		THERAVET TheraVet signe un accord de distribution avec Nuzoa, une société espagnole leader dans la distribution de produits et services vétérinaires 20103015 Pharmaceuticals Other subject
12 May 2022
07:30 CEST 		THERAVET TheraVet : Assemblée générale du 2 juin 2022 : mise à disposition des documents préparatoires 20103015 Pharmaceuticals Other subject
12 May 2022
07:30 CEST 		THERAVET TheraVet: General Meeting of June 2, 2022: Availability of Preparatory Documents 20103015 Pharmaceuticals Other subject
10 May 2022
07:30 CEST 		THERAVET TheraVet Signs an Important Distribution Agreement With the Orthopaedics & Surgical Instrumentation Distributor, Veterinary Instrumentation 20103015 Pharmaceuticals Other subject
10 May 2022
07:30 CEST 		THERAVET TheraVet signe un important accord de distribution avec le distributeur d’instruments orthopédiques et chirurgicaux Veterinary Instrumentation 20103015 Pharmaceuticals Other subject
06 Apr 2022
07:30 CEST 		THERAVET TheraVet publie ses résultats annuels de l’exercice 2021 et confirme ses perspectives ambitieuses de développement et de commercialisation pour 2022 20103015 Pharmaceuticals Other subject
06 Apr 2022
07:30 CEST 		THERAVET TheraVet Reports Full Year 2021 Financial Results and Confirms Its Ambitious Development and Commercial Plans for 2022 20103015 Pharmaceuticals Other subject
28 Mar 2022
07:30 CEST 		THERAVET TheraVet : Mise en œuvre d’un contrat d’animation de marché avec la banque Rothschild 20103015 Pharmaceuticals Other subject
28 Mar 2022
07:30 CEST 		THERAVET TheraVet: Market-making Agreement with Banque Rothschild 20103015 Pharmaceuticals Other subject
15 Mar 2022
07:30 CET 		THERAVET TheraVet : Lancement commercial de BIOCERA-VET® au Royaume-Uni et en Irlande 20103015 Pharmaceuticals Other subject
15 Mar 2022
07:30 CET 		THERAVET TheraVet: Commercial Launch of BIOCERA-VET® in United Kingdom and Ireland 20103015 Pharmaceuticals Other subject
07 Feb 2022
07:30 CET 		THERAVET TheraVet Broadens Its Bone Substitutes Portfolio With an Innovative Line of Biological Bone Grafts 20103015 Pharmaceuticals Other subject
07 Feb 2022
07:30 CET 		THERAVET TheraVet élargit son portefeuille de substituts osseux avec une gamme innovante de greffons biologiques 20103015 Pharmaceuticals Other subject
04 Feb 2022
07:30 CET 		THERAVET TheraVet: Positive Results of BIOCERA-VET®-Bone Surgery Presented at the Annual Conference of the US Veterinary Orthopedic Society and Confirmed on a Larger Patients Cohort 20103015 Pharmaceuticals Other subject
04 Feb 2022
07:30 CET 		THERAVET TheraVet: Résultats positifs de BIOCERA-VET®-Bone Surgery (BS) présentés lors la conférence annuelle de la Veterinary Orthopedic Society (USA) et confirmés sur une plus grande cohorte de patients 20103015 Pharmaceuticals Other subject
25 Jan 2022
07:30 CET 		THERAVET TheraVet Provides Its 2021 Second Half Operational Update 20103015 Pharmaceuticals Other subject
25 Jan 2022
07:30 CET 		THERAVET TheraVet publie son point d’activité du 2nd semestre 2021 20103015 Pharmaceuticals Other subject
18 Jan 2022
07:30 CET 		THERAVET TheraVet renforce son dispositif commercial en France avec la signature d’un important accord de distribution pour le BIOCERA-VET® 20103015 Pharmaceuticals Other subject
18 Jan 2022
07:30 CET 		THERAVET TheraVet Strengthens Its Sales Organisation in France by Signing an Important Distribution Agreement for BIOCERA-VET® 20103015 Pharmaceuticals Other subject
10 Jan 2022
17:58 CET 		THERAVET TheraVet Announces the Initiation of Coverage of Its Stock by Degroof Petercam 20103015 Pharmaceuticals Other subject
10 Jan 2022
17:58 CET 		THERAVET TheraVet annonce l’initiation de la couverture de son titre par Degroof Petercam 20103015 Pharmaceuticals Other subject
16 Dec 2021
07:30 CET 		THERAVET  TheraVet renforce sa gouvernance avec l’arrivée de 3 nouveaux membres indépendants au sein de son conseil d’administration 20103015 Pharmaceuticals Other subject
16 Dec 2021
07:30 CET 		THERAVET TheraVet Is Strengthening Its Corporate Governance With the Appointment of Three New Independent Board Members 20103015 Pharmaceuticals Other subject
09 Dec 2021
07:30 CET 		THERAVET TheraVet : Lancement commercial de BIOCERA-VET® pour l’ostéosarcome canin en Belgique, en France et aux Pays-Bas 20103015 Pharmaceuticals Other subject
09 Dec 2021
07:30 CET 		THERAVET TheraVet: Commercial Launch of BIOCERA-VET® for Canine Osteosarcoma in Belgium, France and The Netherlands 20103015 Pharmaceuticals Other subject
22 Nov 2021
17:45 CET 		THERAVET TheraVet élargit significativement sa gamme BIOCERA-VET® grâce à d’importants accords de distribution et de recherche 20103015 Pharmaceuticals Other subject
22 Nov 2021
17:45 CET 		THERAVET TheraVet Broadens Significantly its BIOCERA-VET® Product Line Through Major Distribution and Research Agreements 20103015 Pharmaceuticals Other subject